Elevated second-trimester maternal serum inhibin A levels in Asian pregnancies with fetal Down syndrome and other chromosomal abnormalities

Fetal Diagnosis and Therapy

Volumn 18, Issue 2, 2003, Pages 105-110

  Hsu, Jenn J ^a   Chiang, Chi H ^a   Hsieh, Ching C ^a   Hsieh, T'sang T ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Asians; Chromosomal abnormalities; Down syndrome; Inhibin A; Prenatal screening

Indexed keywords

INHIBIN A;

ANEUPLOIDY; ARTICLE; ASIAN; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DOWN SYNDROME; EVALUATION; FETUS; FETUS DISEASE; HUMAN; KARYOTYPE 45,X; KARYOTYPE 47,XXY; MATERNAL SERUM; MEASUREMENT; PRIORITY JOURNAL; SAMPLE; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY 13; TRISOMY 18;

ADULT; BIOLOGICAL MARKERS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; ETHNIC GROUPS; FEMALE; FETAL DISEASES; HUMANS; INHIBINS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; STATISTICS, NONPARAMETRIC;

EID: 0037275809     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068070     Document Type: Article

References (33)

1. Hsu JJ, Hsieh TT, Hsieh FJ: Down syndrome screening in an Asian population using α-fetoprotein and free β-hCG: A report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol 1996;87:943-947.
2. Palomaki GE, Knight GJ, McCarthy J, Haddow JE, Donhowe JM: Maternal serum screening for fetal Down syndrome in the United States: A 1995 survey. Am J Obstet Gynecol 1997;176:1046-1051.
3. Macintosh M, Ellis A, Cuckle H, Seth J: Variation in biochemical screening for Down syndrome in the United Kingdom. Br J Obstet Gynaecol 1998;105:465-467.
4. Chard T, Macintosh CM: Screening for Down syndrome. J Perinat Med 1995;23:421-426.
5. Hsu JJ, Hsieh TT, Soong YK, Spencer K: Comparison of Down syndrome screening strategies in Asians combining serum-free β-hCG and α-fetoprotein with maternal age. Prenat Diagn 1997;17:707-716.
6. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
7. Ying SY: Inhibin, activins, and follistatin: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-293.
8. Wallace EM, Grant VE, Swanston IA, Groome NP: Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down syndrome. Prenat Diagn 1995;15:359-362.
9. Noble PL, Wallace EM, Snijders RJ, Groome NP, Nicolaides KH: Maternal serum inhibin-A and free β-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1997;104:367-371.
10. Cuckle HS, Holding S, Johns R, Wallace EM, Groome NP: Maternal serum dimeric inhibin A in second-trimester Down syndrome pregnancies. Prenat Diagn 1995;15:385-392.
11. Aitken DA, Wallace EM, Crossley JA, Swanston IA, Pareren Y, Maarle M, Groome NP, Macri JN, Connor JM: Dimeric inhibin A as a marker for Down syndrome in early pregnancy. N Engl J Med 1996;334:1231-1236.
12. Spencer K, Wallace EM, Ritoe S: Second-trimester dimeric inhibin-A in Down syndrome screening. Prenat Diagn 1996;16:1101-1110.
13. Wallace EM, Swanston IA, McNeilly AS, Ashby JP, Blundell G, Calder AA, Groome NP: Second trimester screening for Down syndrome using maternal serum dimeric inhibin A. Clin Endocrinol 1996;44:17-21.
14. Wenstrom KD, Owen J, Chu DC, Boots L: Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies. Am J Obstet Gynecol 1997;177:992-996.
15. Renier MA, Vereecken A, Van Herck E, Straetmans D, Ramaekers P, Buytaert P: Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down syndrome. Hum Reprod 1998;13:744-748.
16. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG: Prenatal screening for Down syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-153.
17. Wenstrom KD, Owen J, Chu DC, Boots L: α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome. Am J Obstet Gynecol 1997;177:987-991.
18. O'Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI: Race-ethnicity-specific variation in multiple-marker biochemical screening: α-Fetoprotein, hCG, and estriol. Obstet Gynecol 1997;89:355-358.
19. Hsu JJ, Ho HJ, Hsieh TT, Soong YK: Measurement of serum dimeric inhibin A concentrations during the second trimester in Taiwanese pregnancies. Adv Obstet Perinatol 1999;10:229-238.
20. Santoro N, Schneyer AL, Ibrahim J, Schimidt C: Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol 1992;79:579-585.
21. Qu J, Thomas K: Inhibin and activin production in human placenta. Endocr Rev 1995;16:485-507.
22. Watt HC, Wald NJ, Huttly WJ: The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancy. Prenat Diagn 1998;18:846-848.
23. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Ellis PM, Aitken DA, Groome NP: Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997;82:218-222.
24. Healy DL, Polson D, Yohkachiya T, De Krester D: Inhibin and related peptides in pregnancy. Baillières Clin Endocrinol Metab 1990;4:233-247.
25. Spencer K, Coombes EJ, Mallard AS, Ward AM: Free β-human choriogonadotropin in Down syndrome screening: A multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992;29:506-518.
26. Lam YH, Tang MHY: Second-trimester maternal serum inhibin-A screening for fetal down syndrome in Asian women. Prenat Diagn 1999;19:463-467.
27. d'Antona D, Wallace EM, Shearing C, Ashby JP, Groome NP: Inhibin A and Pro-αC inhibin in Down syndrome and normal pregnancies. Prenat Diagn 1998;18:1122-1128.
28. Lambert-Messerlian GM, Saller DN Jr, Tumber MB, French CA, Peterson CJ, Canick JA: Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. Prenat Diagn 1998;18:1061-1067.
29. Hsu JJ, Hsieh TT, Liou JD, Soong YK: Maternal serum and amniotic fluid α-fetoprotein in pregnancies with trisomy and other chromosomal abnormalities. J Matern Fetal Invest 1993;3:255-258.
30. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ: Low second trimester serum unconjugated oestriol in pregnancies with Down syndrome. Br J Obstet Gynaecol 1988;95:330-333.
31. Spencer K, Mallard AS, Coombes EJ, Macri JN: Prenatal screening for trisomy 18 with free β-human chorionic gonadotrophin as a marker. Br Med J 1993;307:1455-1458.
32. Saller DN Jr, Canick JA, Schwartz S, Blitzer MG: Multiple-marker screening in pregnancies with hydrops and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992;167:1021-1024.
33. Wenstrom KD, Chu DC, Owen J, Boots L: Maternal serum α-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome. Am J Obstet Gynecol 1998;179:966-970.